Powered by: Motilal Oswal

News

Lilly signs an Additional Voluntary Licensing Agreement on Baricitinib Eli Lilly and Company announced on Monday that it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma; a local pharmaceutical manufacturer of generic medicines. Under the terms of the license, Natco will be collaborating with Lilly to further accelerate and expand the availability of baricitinib in India during this pandemic, improving the local treatment options available to people who are currently battling Covid-19 in India. Lilly received permissio...
Lilly signs an Additional Voluntary Licensing Agreement on Baricitinib
Lilly signs an Additional Voluntary Licensing Agreement on Baricitinib
Source: IANS
17/05/2021 3:11:15 PM
Lilly inks three new pacts to expand availability of baricitinib drug Eli Lilly and Company on Thursday announced that it has issued additional royalty-free, non-exclusive voluntary licenses to the Indian pharmaceutical manufacturers of generic medicines, Dr. Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals, who will be collaborating to accelerate and expand the availability of baricitinib for Covid treatment in India. These three additional voluntary licensing agreements will ensure high quality manufacturing and accessibility of baricitinib du...
Lilly inks three new pacts to expand availability of baricitinib drug
Lilly inks three new pacts to expand availability of baricitinib drug
Source: IANS
13/05/2021 4:15:12 PM
MSN Labs inks deal with Lilly to launch baricitinib MSN Labs (MSN) on Thursday announced it has entered into a royalty free, non-exclusive, voluntary license agreement with Eli Lilly and Company of USA for manufacturing and marketing of baricitinib for Covid-19 in India. The drug baricitinib has been granted a restricted emergency use approval in India by the Central Drugs Standard Control Organization for emergency use in combination with remdesivir for the treatment of suspected or laboratory confirmed Covid-19 in hospitalised adults requ...
MSN Labs inks deal with Lilly to launch baricitinib
MSN Labs inks deal with Lilly to launch baricitinib
Source: IANS
13/05/2021 3:38:55 PM
Eli Lilly signs agreements with Cipla, Lupin and Sun Pharma  Eli Lilly announced that it has issued royalty-free, non-exclusive voluntary licenses to Indian pharmaceutical manufacturers of generic medicines, Cipla Ltd., Lupin Ltd. and Sun Pharmaceutical Industries Ltd., who are collaborating with Lilly to accelerate and expand the availability of baricitinib in India. Lilly is also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses. These voluntary licensing agreements will ensure...
Eli Lilly signs agreements with Cipla, Lupin and Sun Pharma
Eli Lilly signs agreements with Cipla, Lupin and Sun Pharma
Source: IANS
10/05/2021 1:39:18 PM
Eli Lilly signs deals to boost supply of COVID-19 treatment in India BENGALURU  -Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients. The agreements will bolster India's arsenal of drugs to battle its catastrophic second wave of the pandemic, which has led to an acute shortage of coronavirus medicines including remdesivir and tocilizumab. The three Indian drugmakers - Cipla Ltd, Lupin Ltd ...
Eli Lilly signs deals to boost supply of COVID-19 treatment in India
Eli Lilly signs deals to boost supply of COVID-19 treatment in India
Source: Reuters
10/05/2021 11:50:28 AM
India`s Cipla to make and sell Eli Lilly`s baricitinib to treat COVID-19 BENGALURU-Indian drugmaker Cipla Ltd said on Monday it had entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients. The agreement comes at a time when India is struggling with a catastrophic second wave of the pandemic, leading to an acute shortage of coronavirus medicines such as remdesivir and tocilizumab. Baricitinib has been given restricted emergency use approval by India...
India`s Cipla to make and sell Eli Lilly`s baricitinib to treat COVID-19
India`s Cipla to make and sell Eli Lilly`s baricitinib to treat COVID-19
Source: IANS
10/05/2021 9:26:26 AM
Lilly hit by staff accusations, FDA scrutiny at COVID drug factories Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter. The unsigned report, filed April 8 in Lilly’s confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the ...
Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Source: Reuters
6/05/2021 10:31:15 AM
Eli Lilly to donate 400,000 tablets of its COVID-19 treatment to India Eli Lilly and Co said on Tuesday it would make an immediate initial donation of 400,000 tablets of its COVID-19 treatment to the Indian government for eligible hospitalized COVID-19 patients.
Eli Lilly to donate 400,000 tablets of its COVID-19 treatment to India
Eli Lilly to donate 400,000 tablets of its COVID-19 treatment to India
Source: Reuters
4/05/2021 4:43:51 PM
Eli Lilly profit forecast trimmed as vaccines dent U.S. demand for COVID-19 drugs Eli Lilly and Co on Tuesday missed expectations for first-quarter profit and cut the top end of its full-year earnings forecast as demand waned for its COVID-19 antibody therapies with the U.S. vaccine rollout in full swing. Nearly 30% of the U.S. population has been vaccinated against COVID-19, hitting demand for antibody drugs that already suffered from slower-than-expected uptake by hospitals. "We didn't get into this thinking about margins. We wanted to be useful during the...
Eli Lilly profit forecast trimmed as vaccines dent U.S. demand for COVID-19 drugs
Eli Lilly profit forecast trimmed as vaccines dent U.S. demand for COVID-19 drugs
Source: Reuters
28/04/2021 9:24:40 AM
Lilly Singh reveals how Drew Barrymore inspired her Indian-Canadian comedian Lilly Singh has credited Hollywood star Drew Barrymore for becoming the person she is today. Singh made the revelation when Barrymore told her she liked the fact that Lilly was "self-aware and astute to make the kind of call to do a whole new show from the very comfort of your home". The Hollywood star was talking about Lilly's popular show. Barrymore added: "I was so excited to talk with you because as a woman who loves comedy, you were break...
Lilly Singh reveals how Drew Barrymore inspired her
Lilly Singh reveals how Drew Barrymore inspired her
Source: IANS
31/03/2021 12:54:57 PM
Lilly Alzheimer's drug shows benefit on cognition, function in mid-stage trial Eli Lilly and Co on Saturday said its experimental Alzheimer’s drug slowed the rate of decline in a measure of cognition and function by 32% compared with a placebo in a mid-stage trial of patients at an early stage of the mind wasting disease. The drug, donanemab, also showed positive trends that failed to reach statistical significance on a range of secondary trial goals, the company said, providing details for the first time. The 18-month, 272-patient study showed, for instance...
Lilly Alzheimer's drug shows benefit on cognition, function in mid-stage trial
Lilly Alzheimer's drug shows benefit on cognition, function in mid-stage trial
Source: Reuters
13/03/2021 5:18:46 PM